| Authors |
Year
|
Title
|
Journal and link to article
|
| Inglis et al. |
2016
|
Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: the Attention Deficit Hyperactivity Disorder drugs use chronic effects (ADDUCE) study. |
BMJ Open
|
Kovshoff et al.
|
2016 |
Reports of perceived adverse events of stimulant medication on cognition, motivation, and mood: qualitative investigation and the generation of Items for the medication and cognition rating scale |
Journal of Child and Adolescent Psychopharmacology
|
| Gassó et al. |
2016 |
Association of CACNA1C and SYNE1 in offspring of patients with psychiatric disorders. Psychiatry research |
Psychiatry Research
|
| Pina-Camacho et al. |
2016 |
Age at first-episode modulates diagnosis-related structural brain abnormalities in psychosis. |
Schizophrenia Bulletin
|
Persico et al.
|
2015 |
Unmet needs in paediatric psychopharmacology: present scenario and future perspectives. |
European Neuropsychopharmacology
|
| Parellada et al. |
2015 |
Predictors of functional and clinical outcome in early-onset first-episode psychosis.
|
The Journal of Clinical Psychiatry
|
Sanchez-Gistau et al.
|
2015 |
Psychiatric disorders in child and adolescent offspring of patients with schizophrenia and bipolar disorder: a controlled study
|
Schizophrenia Bulletin
|
Garcia-Amador et al.
|
2015 |
Neurological side-effects of antipsychotics in children and adolescents.
|
Journal of Clinical Psychopharmacology
|
Rapado-Castro et al.
|
2015 |
Gender effects on brain changes in early-onset psychosis
|
European Child and Adolescent Psychiatry
|
Sanchez-Gistau et al.
|
2015 |
The affective dimension of early-onset psychosis and its relationship with suicide
|
The Journal of Clinical Psychiatry
|
Pina-Camacho et al.
|
2015 |
Predictors of schizophrenia spectrum disorders in early-onset first episodes of psychosis: a support vector machine model
|
European Child and Adolescent Psychiatry |
Banaschewski et al.
|
2014 |
Health-related quality of life and functional outcomes from a randomized-withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with Attention-Deficit/Hyperactivity Disorder
|
CNS Drugs
|
| Arango et al. |
2014 |
Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naïve patients.
|
Journal of the American Academy of Child & Adolescent Psychiatry
|
| Coghill et al. |
2014 |
Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design
|
Journal of the American Academy of Child and Adolescent Psychiatry
|
| Coghill et al. |
2014 |
Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial |
European Child and Adolescent Psychiatry |
| Janssen et al. |
2014 |
Cortical morphology of adolescents with bipolar disorder and with schizophrenia
|
Schizophrenia Research
|
| Fraguas et al. |
2014 |
A longitudinal study on the relationship between duration of untreated psychosis and executive function in early-onset first-episode psychosis |
Schizophrenia Research
|
| Martínez-Cengotitabengoa et al. |
2014 |
Basal low antioxidant capacity correlates with cognitive deficits in early onset psychosis. A 2-year follow-up study. |
Schizophrenia Research |
| Fraguas et al. |
2014 |
Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: a 2-year longitudinal study.
|
Schizophrenia Research |
Thissen et al.
|
2014 |
Attention-deficit/hyperactivity disorder (ADHD) and motor timing in adolescents and their parents: familial characteristics of reaction time variability vary with age
|
Journal of the American Academy of Child and Adolescent Psychiatry
|
Groenman et al.
|
2014 |
Neurocognitive predictors of substance use disorders and nicotine dependence in ADHD probands, their unaffected siblings, and controls: a 4-year prospective follow-up |
Journal of Child Psychology and Psychiatry
|
| van Ewijk et al. |
2014 |
Different mechanisms of white matter abnormalities in attention-deficit/hyperactivity disorder: a diffusion tensor imaging study
|
Journal of the American Academy of Child and Adolescent Psychiatry
|
| Richards et al. |
2014 |
Differential susceptibility to maternal expressed emotion in children with ADHD and their siblings? Investigating plasticity genes, prosocial and antisocial behaviour. |
European Child & Adolescent Psychiatry
|
| Vorstman et al. |
2014 |
Using genetic findings in autism for the development of new pharmaceutical compounds |
Psychopharmacology (Berl)
|
| Glennon et al. |
2014 |
Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges
|
European Child & Adolescent Psychiatry |
Coghill et al.
|
2013 |
Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
|
BMC Psychiatry
|
Banaschewski et al.
|
2013 |
Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorder |
CNS Drugs
|
| Soutullo et al. |
2013 |
A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents |
CNS Drugs |
| Coghill et al. |
2013 |
European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder |
European Neuropsychopharmacology
|
Bralten et al.
|
2013 |
Candidate genetic pathways for attention-deficit/hyperactivity disorder (ADHD) show association to hyperactive/impulsive symptoms in children with ADHD
|
Journal of the American Academy of Child and Adolescent Psychiatry |
Payá et al.
|
2013 |
Premorbid impairments in early-onset psychosis: differences between patients with schizophrenia and bipolar disorder |
Schizophrenia Research
|
| van der Meer et al. |
2013 |
A randomized, double-blind comparison of atomoxetine and placebo on response inhibition and interference control in children and adolescents with autism spectrum disorder and comorbid attention-deficit/hyperactivity disorder symptoms
|
Journal of Clinical Psychopharmacology
|
| Cross-Disorder Group of the Psychiatric Genomics Consortium et al. |
2013 |
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs.
|
Nature Genetics |
Groenman et al.
|
2013 |
Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder |
British Journal of Psychiatry
|
Mota et al.
|
2013 |
Association between DRD2/DRD4 interaction and conduct disorder: a potential developmental pathway to alcohol dependence |
American Journal of Medical Genetics
|
Harfterkamp et al.
|
2013 |
Long-term treatment with atomoxetine for attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder: an open-label extension study |
Journal of Child and Adolescent Psychopharmacology
|
| Murray et al. |
2013 |
An inventory of European data sources for the long-term safety evaluation of methylphenidate
|
European Child & Adolescent Psychiatry |
| Sonuga-Barke et al. |
2013 |
Non pharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments
|
American Journal of Psychiatry |
Cortese et al.
|
2013 |
Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents
|
Journal of Child Psychology and Psychiatry |
| Dietrich et al. |
2013 |
Cortisol in the morning and dimensions of anxiety, depression, and aggression in children from a general population and clinic-referred cohort: An integrated analysis. The TRAILS study |
Psychiatry
|
| Noguera et al. |
2013 |
Twenty-four months of antipsychotic treatment in children and adolescents with first psychotic episode: discontinuation and tolerability |
Journal of Clinical Psychopharmacology
|
| Banaschewski et al. |
2012 |
Neuropsychological correlates of emotional lability in children with ADHD |
Journal of Child Psychology and Psychiatry |
| Toplak et al. |
2012 |
The hierarchical factor model of ADHD: invariant across age and national groupings? |
Journal of Child Psychology and Psychiatry |
| Fraguas et al. |
2012 |
Decreased glutathione levels predict loss of brain volume in children and adolescents with first-episode psychosis in a two-year longitudinal study. |
Schizophrenia Research
|
Arango et al.
|
2012 |
Progressive brain changes in children and adolescents with first-episode psychosis
|
JAMA Psychiatry
|
| Mayoral et al. |
2012 |
Longitudinal study of neurological soft signs in first-episode early-onset psychosis
|
Journal of Child Psychology and Psychiatry |
Cavanna et al.
|
2012 |
From ipse dixit to evidence-based guidelines: on the optimal management of Tourette syndrome
|
European Journal of Paediatric Neurology |
